InvestorsObserver is giving Graphite Bio Inc (GRPH) an Analyst Rating Rank of 4, meaning GRPH is ranked higher by analysts than 4% of stocks. The average price target for GRPH is $3.75 and analyst’s rate the stock as a Hold.
Wall Street analysts are rating GRPH a Hold today. Find out what this means to you and get the rest of the rankings on GRPH!